OTCM
HYEX
Market cap686mUSD
May 21, Last price
1.99USD
1D
-11.67%
Jan 2017
-99.92%
IPO
-99.99%
Name
Healthy Extracts Inc
Chart & Performance
P/E
—
P/S
220.63
EPS
—
Div Yield, %
—
Shrs. gr., 5y
26.44%
Rev. gr., 5y
32.99%
Revenues
3m
+25.24%
Net income
-841k
L-66.01%
CFO
282k
P
Profile
Healthy Extracts Inc., through its subsidiaries, researches, develops, and markets natural plant-based products in the United States and internationally. It offers heart health nutritional supplements; and neuro products under the KETONOMICS name that enhance brain health, including memory, cognition, focus, and neuro-energy. The company also provides bergamot products in capsule form under the BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART products labels. It distributes bergamot products through its website and distribution sites. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is based in Littleton, Colorado.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | 3,113 25.24% | 2,486 10.41% | 2,251 53.60% | |||||||
Cost of revenue | 3,296 | 4,730 | 4,142 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (183) | (2,244) | (1,891) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 7 | |||||||||
Tax Rate | ||||||||||
NOPAT | (183) | (2,244) | (1,898) | |||||||
Net income | (841) -66.01% | (2,473) 149.80% | (990) -51.46% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (5) | (90) | (11) | |||||||
BB yield | 0.43% | 0.08% | ||||||||
| Debt | ||||||||||
Debt current | 942 | 1,128 | 594 | |||||||
Long-term debt | 9 | 74 | ||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 1 | |||||||||
Net debt | 839 | 1,183 | 528 | |||||||
| Cash flow | ||||||||||
Cash from operating activities | 282 | (416) | (335) | |||||||
CAPEX | (1) | (8) | ||||||||
Cash from investing activities | (8) | |||||||||
Cash from financing activities | (189) | 370 | 240 | |||||||
FCF | 622 | (1,953) | 449 | |||||||
| Balance | ||||||||||
Cash | 112 | 19 | 66 | |||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | (18,886) | (18,045) | (15,582) | |||||||
Invested Capital | 20,238 | 20,127 | 18,053 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | 2,979 | 2,915 | 2,854 | |||||||
Price | 7.20 50.00% | 4.80 -14.71% | ||||||||
Market cap | 20,991 53.21% | 13,701 -8.49% | ||||||||
EV | 22,173 | 14,228 | ||||||||
EBITDA | (183) | (2,242) | (1,890) | |||||||
EV/EBITDA | ||||||||||
Interest | 65 | |||||||||
Interest/NOPBT | ||||||||||